COMPARATIVE-STUDY ON HUMAN PHARMACOKINETICS OF ACTIVATED IFOSFAMIDE AND CYCLOPHOSPHAMIDE BY A MODIFIED FLUOROMETRIC TEST

被引:96
作者
WAGNER, T [1 ]
HEYDRICH, D [1 ]
JORK, T [1 ]
VOELCKER, G [1 ]
HOHORST, HJ [1 ]
机构
[1] MED HSCH LUBECK,MED KLIN,D-2400 LUBECK,FED REP GER
关键词
D O I
10.1007/BF00405906
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:95 / 104
页数:10
相关论文
共 26 条
[11]  
FRIEDMAN OM, 1979, ADV CANCER CHEMOTHER
[12]  
HOHORST HJ, 1976, CANCER TREAT REP, V60, P309
[13]  
HOHORST HJ, 1976, CANCER RES, V36, P2278
[14]  
MELLETT LB, 1969, PHARMACOLOGIST, V11, P273
[15]  
NORPOTH K, 1976, CANCER TREAT REP, V60, P437
[16]  
NORPOTH K, 1976, ARZNEIMFORSCH DRUG R, V25, P1376
[17]  
PETER G, 1976, CANCER TREAT REP, V60, P429
[18]   MASS-SPECTROMETRIC CHARACTERIZATION OF ACTIVATED N-(2-CHLOROETHYL)AMIDO OXAZAPHOSPHORINE DERIVATIVES [J].
PRZYBYLSKI, M ;
RINGSDORF, H ;
LENSSEN, U ;
PETER, G ;
VOELCKER, G ;
WAGNER, T ;
HOHORST, HJ .
BIOMEDICAL MASS SPECTROMETRY, 1977, 4 (04) :209-215
[19]  
SACHS L, 1969, STATISTISCHE AUSWERT, P293
[20]  
SCHAUMLOFFEL E, 1977, 1977 VORTR INT HOL S